Trends in Outpatient Care Delivery and Telemedicine During the COVID-19 Pandemic in the US

Patel, Sadiq; Mehrotra, Ateev; Huskamp, Haiden A.; Uscher‐Pines, Lori; Ganguli, Ishani; Barnett, Michael L.

doi:10.1001/jamainternmed.2020.5928

Cited by 462 publications

(472 citation statements)

References 1 publication

Supporting

Mentioning

444

Contrasting

Unclassified

Order By: Relevance

“…A recent study 28 examined telehealth provided by a national panel of several thousand primary care physicians participating in the IQVIA (formerly IMS Health) national disease and therapeutic index audit. A few other recent studies 29 , 30 , 31 also leveraged large claims databases, such as the OptumLabs/United, Castlight Health, and the FAIR Health multipayer database, to study changes in health services use and telehealth adoption. Other recent studies have explored different aspects of COVID-19 era telehealth utilization for selected clinical conditions 32 and specific patient groups.…”

Section: Discussionmentioning

confidence: 99%

In-Person and Telehealth Ambulatory Contacts and Costs in a Large US Insured Cohort Before and During the COVID-19 Pandemic

et al. 2021

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

In-Person and Telehealth Ambulatory Contacts and Costs in a Large US Insured Cohort Before and During the COVID-19 Pandemic

et al. 2021

View full text Add to dashboard Cite

show abstract

“…2 The pandemic compelled states, payers, and providers to overcome the long-standing implementation and financial barriers to telemedicine adoption. 3 COVID-19 stimulated the establishment of a ''new normal'' for virtual, synchronous care that could become a standard of care moving forward. 4 Although telemedicine has been critical for maintaining continuity of care in the midst of public health precautions, concerning trends related to equity and access have emerged, including disparities in race, age, and geography.…”

mentioning

confidence: 99%

Understanding Telemedicine's “New Normal”: Variations in Telemedicine Use by Specialty Line and Patient Demographics

Drake

Lian

Cameron

et al. 2022

Telemedicine and e-Health

126

View full text Add to dashboard Cite

Background: Our objective was to examine the variation in telemedicine adoption by specialty line and patient demographic characteristics after the initial peak period of the coronavirus disease 2019 pandemic when in-person visits had resumed and visit volume returned to prepandemic levels. Materials and Methods: Aggregated encounter data were extracted for six service lines (dermatology, psychiatry, endocrinology, cardiology, orthopedics, and nonurgent primary care) in an integrated health system across three time periods:

show abstract

“…The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) has led to reductions in outpatient medical care and routine preventive screening for cancer and diabetes mellitus [1] , [2] , [3] . Cardiovascular disease is the leading cause of mortality in the U.S. [4] .…”

mentioning

confidence: 99%

Trends in cholesterol testing during the COVID-19 pandemic

Gumuser¹,

Haidermota²,

Finneran³

et al. 2021

American Journal of Preventive Cardiology

View full text Add to dashboard Cite

Objective To characterize trends in cholesterol testing since the start of the COVID-19 pandemic. Methods We extracted testing for total cholesterol performed in adults ≥40 years old within the Mass General Brigham healthcare system between March and September 2020, as well those performed between March and September 2019 (reference period). Weekly cholesterol testing rates during the 2020 vs. 2019 study periods were compared using the paired samples t -test. Secondary analyses compared testing volumes and patient characteristics during the first vs. second half of the 2020 study period. Results The study sample included 296,599 tests for total cholesterol performed in 220,215 individuals. The mean (SD) weekly cholesterol tests performed were 6,361 (682) in 2019 vs. 3,867 (2,373) in 2020 ( P = 2.6 × 10 −5 ), representing an overall decline of 39.2%. However, weekly testing rates in 2020 were not uniform. Greatest reductions coincided with the “first wave” of the pandemic (March-May 2020), with up to 92% reductions in testing observed. In the first 14 weeks of each study period (March to mid-June), weekly testing rates were 71.8% lower in 2020. Among individuals tested in 2020, those tested between March and mid-June had substantially lower total cholesterol compared with individuals tested after mid-June (174.2 vs. 181.5 mg/dL, P <2.2 × 10 −16 ). Conclusions In a large integrated healthcare system, cholesterol testing rates were 39% lower between March-September 2020 compared with the same time period in 2019. Mechanisms for safely facilitating cholesterol testing and management for high-risk patients will be important as COVID-19 re-surges across the U.S. until widespread vaccination and population immunity allow resumption of routine preventive care.

show abstract

Trends in Outpatient Care Delivery and Telemedicine During the COVID-19 Pandemic in the US

Abstract: however, the meeting was canceled due to the coronavirus disease 2019 pandemic.

Cited by 462 publications

References 1 publication

In-Person and Telehealth Ambulatory Contacts and Costs in a Large US Insured Cohort Before and During the COVID-19 Pandemic

In-Person and Telehealth Ambulatory Contacts and Costs in a Large US Insured Cohort Before and During the COVID-19 Pandemic

Understanding Telemedicine's “New Normal”: Variations in Telemedicine Use by Specialty Line and Patient Demographics

Trends in cholesterol testing during the COVID-19 pandemic

Contact Info

Product

Resources

About